文献速递临床试验与 GCP流行病学与生物统计

清醒俯卧位通气在非插管自主呼吸重症监护病房急性低氧性呼吸衰竭患者中的随机临床试验(PRONELIFE)研究方案

Awake prone positioning in nonintubated spontaneous breathing ICU patients with acute hypoxemic respiratory failure (PRONELIFE)-protocol for a randomized clinical trial.
PubMed 文献 · Trials · 2022-01-10

PRONELIFE是一项由研究者发起的国际多中心随机临床试验,纳入因急性低氧性呼吸衰竭可能需要有创通气的ICU患者,随机分配至清醒俯卧位联合标准治疗组或不联合清醒俯卧位的标准治疗组。主要终点为入组后14天内气管插管与全因死亡率的复合终点,次要终点包括插管时间、氧合参数、呼吸困难及并发症等。该研究旨在确定清醒俯卧位对插管率的影响,其结果可能改变此类患者的临床管理。

要点

  • PRONELIFE研究纳入因急性低氧性呼吸衰竭可能需要有创通气的ICU患者,比较清醒俯卧位联合标准治疗与单纯标准治疗。
  • 主要终点为入组后14天内气管插管与全因死亡的复合终点。
  • 该研究为实用性试验且无法设盲,全球约35个ICU参与,结果具有高度可推广性。

核心结论

  • PRONELIFE研究旨在确定清醒俯卧位对因急性低氧性呼吸衰竭可能需要有创通气的ICU患者插管率的影响,其结果可能改变此类患者的临床管理。

研究设计与样本

  • PRONELIFE是一项由研究者发起的国际多中心随机临床试验,纳入因急性低氧性呼吸衰竭可能需要有创通气的患者。
  • 连续入住参与ICU的患者被随机分配至清醒俯卧位联合标准治疗组或不联合清醒俯卧位的标准治疗组。
  • 主要终点为入组后14天内气管插管与全因死亡的复合终点。
  • 次要终点包括气管插管时间、清醒俯卧位对氧合参数、呼吸困难感觉及并发症的影响。
  • 其他终点包括28天无通气且存活天数、无创呼吸支持总时长、有创通气总时长、ICU及住院时间、ICU及住院死亡率以及28天、60天和90天死亡率,并收集俯卧位耐受性数据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • PRONELIFE为实用性试验,无法设盲。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is uncertain whether awake prone positioning can prevent intubation for invasive ventilation in spontaneous breathing critically ill patients with acute hypoxemic respiratory failure. Awake prone positioning could benefit these patients for various reasons, including a reduction in direct harm to lung tissue, and prevention of tracheal intubation-related complications. DESIGN AND METHODS: The PRONELIFE study is an investigator-initiated, international, multicenter, randomized clinical trial in patients who may need invasive ventilation because of acute hypoxemic respiratory failure. Consecutive patients admitted to participating ICUs are randomly assigned to standard care with awake prone positioning, versus standard care without awake prone positioning. The primary endpoint is a composite of tracheal intubation and all-cause mortality in the first 14 days after enrolment. Secondary endpoints include time to tracheal intubation and effects of awake prone positioning on oxygenation parameters, dyspnea sensation, and complications. Other endpoints are the number of days free from ventilation and alive at 28 days, total duration of use of noninvasive respiratory support, total duration of invasive ventilation, length of stay in ICU and hospital, and mortality in ICU and hospital, and at 28, 60, and 90 days. We will also collect data regarding the tolerance of prone positioning. DISCUSSION: The PRONELIFE study is among the first randomized clinical trials investigating the effect of awake prone positioning on intubation rate in ICU patients with acute hypoxemic failure from any cause. The PRONELIFE study is sufficiently sized to determine the effect of awake prone positioning on intubation for invasive ventilation-patients are eligible in case of acute hypoxemic respiratory failure without restrictions regarding etiology. The PRONELIFE study is a pragmatic trial in which blinding is impossible-however, as around 35 ICUs worldwide will participate in this study, its findings will be highly generalizable. The findings of the PRONELIFE study have the potential to change clinical management of patients who may need invasive ventilation because of acute hypoxemic respiratory failure. TRIAL REGISTRATION: ISRCTN ISRCTN11536318 . Registered on 17 September 2021. The PRONELIFE study is registered at clinicaltrials.gov with reference number NCT04142736 (October, 2019).

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Morales-Quinteros L, Schultz MJ, Serpa-Neto A, et al. Awake prone positioning in nonintubated spontaneous breathing ICU patients with acute hypoxemic respiratory failure (PRONELIFE)-protocol for a randomized clinical trial. Trials. 2022. PMID: 35012606. doi:10.1186/s13063-021-05991-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。